XML 54 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign

The loss from operations before tax (expense) benefit consisted of the following for the years ended December 31, 2021, 2020, and 2019:

    

2021

    

2020

    

2019

Domestic

$

(487,726)

$

(452,475)

$

(231,915)

Foreign

 

(30,614)

 

49,543

 

(8,011)

Total

$

(518,340)

$

(402,932)

$

(239,926)

Components of Income Tax Provision

The Income Tax Provision consisted of the following for the years ended December 31, 2021, 2020 and 2019:

    

2021

    

2020

    

2019

Current:

 

  

 

  

 

  

U.S. Federal

$

$

$

U.S. State and Local

 

(3,844)

 

(24,984)

 

(61)

Foreign

 

(1,340)

 

(4,372)

 

(2,041)

Deferred:

 

  

 

  

 

  

U.S. Federal

 

 

 

U.S. State and Local

 

(377)

 

(5,872)

 

(8,812)

Foreign

 

 

 

(736)

Total tax expense

$

(5,561)

$

(35,228)

$

(11,650)

Schedule of reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate

A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:

    

December 31, 

 

    

2021

    

2020

    

2019

 

Federal income tax provision at statutory rate

21.00

%  

21.00

%  

21.00

%  

State income tax provision, net of federal benefit

(0.74)

 

(3.31)

 

1.08

 

Permanent differences

(4.06)

 

(6.66)

 

(6.17)

 

Research and development

4.50

 

4.93

 

4.38

 

Change in valuation allowances

(29.03)

 

(26.40)

 

(35.49)

 

Change in deferred tax assets

12.05

 

2.93

 

15.89

 

Foreign tax rate differential

0.01

 

0.72

 

(1.88)

 

Tax rate change

0.01

 

(1.46)

 

(3.67)

 

(Accrual) Release of uncertain tax positions

(4.78)

(0.61)

Other

(0.03)

 

0.12

 

 

Effective income tax rate

(1.07)

%  

(8.74)

%  

(4.86)

%

Schedule of significant components of the Company's deferred tax assets and liabilities

    

December 31, 

2021

    

2020

Assets:

 

  

 

  

Noncurrent deferred income taxes

$

$

Liabilities:

 

  

 

  

Noncurrent deferred income taxes

 

(137,110)

 

(136,735)

Deferred income taxes - net

$

(137,110)

$

(136,735)

The significant components of the Company’s deferred tax assets and liabilities at December 31, 2021 and 2020 are as follows:

    

2021

    

2020

Deferred tax assets:

 

  

 

  

Accrued expense

$

8,208

$

5,528

Amortization

 

87,998

 

80,677

Depreciation

 

 

Federal tax credits

 

142,595

 

123,405

State tax credits

 

8,054

 

Federal net operating losses

 

76,589

 

16,999

State net operating losses

 

9,159

 

1,428

Foreign net operating losses

 

3,316

 

Capitalized research and development costs

 

241

 

661

Share based compensation and other

 

15,273

 

14,612

Liability for sale of future royalties

148,503

161,204

Noncash interest expense

26,040

Other comprehensive loss

 

143

 

7,624

Total gross deferred tax assets

 

526,119

 

412,138

Less valuation allowance

 

(525,570)

 

(379,608)

Total deferred tax assets, net of valuation allowance

$

549

$

32,530

Deferred tax liabilities:

 

  

 

  

Depreciation

$

(549)

$

(2,904)

Convertible debt

(29,626)

Indefinite lived intangible

 

(137,110)

 

(136,735)

Total gross deferred tax liabilities

 

(137,659)

 

(169,265)

Net deferred tax assets (liabilities)

$

(137,110)

$

(136,735)

Schedule of unrecognized tax benefits

A reconciliation of the gross amount of unrecognized tax benefits, excluding accrued interest and penalties, is as follows:

Unrecognized Tax Benefits

Balance at December 31, 2020

2,446

Additions based on tax positions related to the current year

 

24,771

Balance at December 31, 2021

$

27,217